ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIOG Biotech Growth Trust (the) Plc

942.00
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 942.00 933.00 939.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt -32.42M -41.3M -1.0034 -9.31 384.42M

The Biotech Growth Trust Plc - Compliance with Market Abuse Regulation

23/04/2019 9:42am

PR Newswire (US)


Biotech Growth (LSE:BIOG)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Biotech Growth Charts.

The Biotech Growth Trust PLC (“the Company”)

Compliance with Market Abuse Regulation

23 April 2019

The Company confirms that:

a)         all inside information which the Directors and Company may have had has been notified to a Regulated Information Service (“RIS”);

b)         the Company’s net asset value per share is calculated and announced through a RIS on a daily basis;

c)         the Company has no reason to believe that there will be any material difference between the net asset value per share as at close of business on Friday 29 March 2019, which was announced on Monday, 1 April 2019, and the financial information to be published in the announcement of its results for the year ended 31 March 2019.

The Company is, therefore, not prohibited from dealing in its own securities during the closed period, as defined by the EU Market Abuse Regulation, which will end on the date of the publication of its results for the year ended 31 March 2019, expected to be on or after 24 May 2019. 

-ENDS-

For further information please contact:

Mark Pope      Frostrow Capital LLP - 020 3 008 4913

Copyright l 23 PR Newswire

1 Year Biotech Growth Chart

1 Year Biotech Growth Chart

1 Month Biotech Growth Chart

1 Month Biotech Growth Chart

Your Recent History

Delayed Upgrade Clock